Open Beta
MetriLume

US marketsQTTB

SEC-sourced researchBeta

QTTB

Q32 Bio Inc.

Company comparison ↗

Data passport

CIK
0001661998
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 30, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 0.0000 USD; December 2025: 53,737,000.0000 USD53.7M USD0 USD0December 2024December 2025
QTTB · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20240.0000Mar 10, 2026
December 202553,737,000.0000Mar 10, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202553,737,000.000029,821,000.0000-33,543,000.000061,776,000.000019,762,000.0000Mar 10, 2026
December 20240.0000-47,733,000.0000-67,715,000.000092,332,000.000086,657,000.0000Mar 10, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$53.74MDecember 2025Mar 10, 202610-K
Previous period revenueRevenues$0December 2024Mar 10, 202610-K
Net incomeNetIncomeLoss$29.82MDecember 2025Mar 10, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$33.54MDecember 2025Mar 10, 202610-K
Total assetsAssets$61.78MDecember 2025Mar 10, 202610-K
Total liabilitiesLiabilities$19.76MDecember 2025Mar 10, 202610-K

New filings

Explore methodology ↗